From: “Dr. David Scarfe”
Date: 27 December 2012 2:23:30 AWST
Subject: AquaVetMed: New approaches for fish vaccination – using fly larvae
December 26, 2013
Bionaturis project launches vaccination of farmed fish with oral vaccines
Spain – Bionaturis, a biotechnology company, has launched the Aquafly project in collaboration with the Department of Chemical Engineering, Food Technology and Environmental Technologies, Faculty of Sciences, University of Cadiz and the Technological Centre of Andalusia Aquaculture (Ctaqua) to more effective alternatives in farmed fish vaccination.
The idea for the project came from internal developments in Bionaturis for aquaculture, after meeting the needs of industry through meetings held recently with producers and national and international veterinary companies operating in the sector. The technical objective is research and development of new prophylactic and therapeutic vaccines orally, based on the production platform and Flylife system (use of insect larvae as bioreactors for the production of biological drugs) which can be used more efficient and safe from diseases affecting current aquaculture. The research program, which will run for three years, is led by Ana de las Heras, doctor of veterinary science and scientific Bionaturis. This project has been funded by the Technological Corporation of Andalusia (CTA).
The increased density of animals in farms results in a higher concentration of pathogens and disease onset in these fish. Experts estimate that 20 percent of aquaculture production is lost due to the onset of disease. Some of the major diseases that cause significant losses in these sectors will be studied in the project Aquafly.
Thanks to our technology platform Flylife, highlights Ana de las Heras, “develop vaccines and other treatments to be administered orally in a safe and effective against some major pathogens affecting current aquaculture”. For this sector, will represent “a breakthrough”, and that “so far, for most treatments, injection is the only way that has proved really effective, but has major limitations due to cost and management. Not only stress generated by handling, fish size limits the use of injectable vaccines in smaller fish, which is more convenient and effective vaccination against some pathogens. ”
This project is aimed at pathogens and species most important in Andalusia, coupled with the participation in the European project Targetfish. It is oriented at viral vaccines and other species in Europe and ratifies Bionaturis as a leader in the research and development of vaccines for aquaculture, a sector of exponential growth in the coming years.
See the source (http://www.20minutos.es/noticia/1684052/0/) for the full story, and http://www.youtube.com/watch?v=hF6MNIBKkXU for a video clip of the Aquafly project (in Spanish).
___________________________
AquaVetMed e-News provides information to veterinary and veterinary-allied subscribers concerning aquatic animal medicine, health, welfare, public health and seafood safety, obtained from a variety of sources (largely AquaVetMed subscribers). While provided by the American Veterinary Medical Association’s, Aquatic Veterinary Medicine Committee and are for public distribution, they do not necessarily reflect the opinion of the AVMA or the veterinary profession. See the AVMA Terms of Use (http://tinyurl.com/29h2rf) for further information.
If e-News information is used elsewhere please acknowledge AquaVetMed as the source. Encourage individuals to subscribe rather than distribute through list serves.
Messages may contain attachments that will have been scanned for known viruses.
Subscription and Contributions: Interested veterinarians and veterinary-allied professionals can subscribe, unsubscribe, or contribute pertinent news or information, by sending a message with “For AquaVetMed -” and the topic in the subject line, to dscarfe@avma.org.
Note: Undelivered e-mails will not be resent; Subscribers will be deleted from the list after repeated undelivered or bounced messages and will have to re-subscribe.
Visit our website: http://www.avma.org
__________________________
